On the other hand, the use of metformin may affect the development of IBD, probably through its exceptional ability to change the gut microbiota, to maintain or reduce body weight, to modulate autoimmunity, and to inhibit the mTOR pathway. This evidence concerns the gene MTOR and Autoimmunity.